Disc Medicine Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	342.62	360.38	194.61	88.04	4.5	3.31
Cash & Cash Equivalents	342.62	360.38	194.61	88.04	4.5	3.31
Cash Growth	44.92%	85.18%	121.06%	1855.05%	36.08%	-
Other Current Assets	9.33	5.28	3.88	2.45	0.56	1.92
Total Current Assets	351.95	365.66	198.49	90.48	5.07	5.23
Property, Plant & Equipment	2	2.1	1.6	1.75	0.29	0.59
Long-Term Investments	0	0	0	0	0.32	0
Other Long-Term Assets	0.24	0.23	0.12	0.18	2.64	0.33
Total Long-Term Assets	2.23	2.33	1.71	1.93	3.25	0.92
Total Assets	354.18	368	200.21	92.41	8.32	6.14
Accounts Payable	5.27	12.63	16.16	2.56	2.38	3.8
Current Debt	0.77	0.67	0.31	0.32	16.69	2.5
Other Current Liabilities	8.82	8.15	6.11	10.55	5.81	2.69
Total Current Liabilities	14.85	21.44	22.58	13.42	24.88	8.99
Long-Term Debt	1.26	1.44	1.03	1.33	4.95	7.41
Other Long-Term Liabilities	0	0	0	0	0.35	0.18
Total Long-Term Liabilities	1.26	1.44	1.03	1.33	5.3	7.59
Total Liabilities	16.11	22.88	23.61	14.76	30.18	16.58
Total Debt	2.03	2.1	1.33	1.65	21.64	9.91
Debt Growth	61.05%	57.50%	-19.30%	-92.36%	118.34%	-
Retained Earnings	-215.59	-188.65	-112.22	-65.39	-112.82	-71.98
Shareholders' Equity	338.07	345.12	176.6	-64.2	-21.86	-70.8
Net Cash / Debt	340.59	358.28	193.28	86.38	-17.14	-6.6
Net Cash / Debt Growth	44.83%	85.37%	123.74%	-	-	-
Net Cash Per Share	13.73	16.05	185.93	98.34	-11.34	-12.77
Working Capital	337.1	344.22	175.91	77.06	-19.81	-3.76
Book Value Per Share	13.63	15.46	169.89	-73.09	-14.46	-136.90

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).